Over a month ago |
Recommendations
|
Morgan Stanley analyst… Morgan Stanley analyst Craig Hettenbach lowered the firm's price target on Sharecare to $2 from $2.50 and keeps an Equal Weight rating on the shares. The company's guidance was "well below the Street," but "seems to bake in conservative assumptions," said the firm, which lowered its own estimates following the company's quarterly report. ShowHide Related Items >><< - 02/27/23
- Sharecare expands home offerings beyond Medicare Advantage
- 03/30/23 BTIG
- Sharecare's results, core fundamentals better than they appear, says BTIG
- 01/03/23 BTIG
- Sharecare named Top Pick for first half of 2023 at BTIG
- 11/11/22 Canaccord
- Sharecare price target lowered to $3 from $4 at Canaccord
- 11/11/22 Canaccord
- Sharecare price target lowered to $3 from $4 at Canaccord
- 03/29/23
- Sharecare sees FY23 revenue $450M-$460M, consensus $518.49M
- 03/29/23
- Sharecare sees Q1 revenue $111M-$113M, consensus $118.8M
- 03/29/23
- Sharecare reports Q4 adjusted EPS (2c), consensus (5c)
- 11/10/22
- Sharecare reports Q3 adjusted EPS (1c), consensus (6c)
- 03/29/23
- What You Missed On Wall Street On Wednesday
- 03/29/23
- What You Missed On Wall Street This Morning
|
Recommendations
|
BTIG analyst David Larsen… BTIG analyst David Larsen notes Sharecare's stock sold off after the company reported Q4 2022 results, due mainly to the 2023 guidance which came in well behind consensus expectations. While the reported numbers are lower than expectations the firm's view is that the core business is still doing well. BITG notes that Sharecare continues to add about 15+ new Enterprise clients each year, utilization levels of the platform are high, large and high-profile clients are being added like BCBS of Michigan, CareFirst was renewed, the technology itself is very effective and durable, and Sharecare's gross margin is good, at 50%+. The firm maintains a Buy rating on the stock with a price target of $5. ShowHide Related Items >><< - 02/27/23
- Sharecare expands home offerings beyond Medicare Advantage
- 01/03/23 BTIG
- Sharecare named Top Pick for first half of 2023 at BTIG
- 11/11/22 Canaccord
- Sharecare price target lowered to $3 from $4 at Canaccord
- 11/11/22 Canaccord
- Sharecare price target lowered to $3 from $4 at Canaccord
- 10/19/22 BTIG
- Sharecare 'obvious beneficiary' of Elevance growth, says BTIG
- 03/29/23
- Sharecare sees FY23 revenue $450M-$460M, consensus $518.49M
- 03/29/23
- Sharecare sees Q1 revenue $111M-$113M, consensus $118.8M
- 03/29/23
- Sharecare reports Q4 adjusted EPS (2c), consensus (5c)
- 11/10/22
- Sharecare reports Q3 adjusted EPS (1c), consensus (6c)
- 03/29/23
- What You Missed On Wall Street On Wednesday
- 03/29/23
- What You Missed On Wall Street This Morning
|
On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - 03/06/23
- Urban Outfitters COO Conforti sells 42,000 common shares
- 02/28/23
- Urban Outfitters says Q1 revenue growth could be 'similar to Q4'
- 02/28/23
- Urban Outfitters reports comparable retail segment sales up 3%
- 01/09/23
- Urban Outfitters reports holiday sales increased 2.3%
- 03/20/23
- UBS rises 7.9%
- 03/19/23
- Fly Intel: Top five weekend stock stories
- 03/29/23
- Nano Dimension increases offer to acquire Stratasys to $19.55 per share
- 03/23/23
- Nano Dimension to review options relative to Stratasys and alternative targets
- 03/22/23
- Stratasys up 4.5% at $15.25 as its board rejects Nano Dimension offer
- 03/22/23
- Stratasys board unanimously rejects acquisition proposal from Nano Dimension
- 03/13/23
- SomaLogic delivers 28M proteomic data points on CKB samples
- 01/05/23
- Cathie Wood's ARK Investment bought 415.4K shares of SomaLogic today
- 01/04/23
- Cathie Wood's ARK Investment bought 313K shares of SomaLogic today
- 01/03/23
- Cathie Wood's ARK Investment bought 288K shares of SomaLogic today
- 02/27/23
- Sharecare expands home offerings beyond Medicare Advantage
- 11/17/22
- Ross Stores jumps 15% to $112.50 after Q3 results beat, FY22 EPS view raised
- 11/14/22
- Soros Fund Management buys Sierra Wireless, exits Kinder Morgan in Q3
- 10/16/22
- Fly Intel: Top five weekend stock stories
- 03/23/23
- Progress Software offers free training, certification for Progress OpenEdge
- 02/07/23
- Progress Software completes acquisition of MarkLogic
- 01/19/23
- Progress Software releases Progress Telerik, Progress Kendo UI
- 01/03/23
- Progress Software to acquire MarkLogic for $355M
- 03/28/23
- Dave & Buster's says Q1 QTD SSS roughly flat to down very low single digits
- 03/28/23
- Dave & Buster's announces $100M share repurchase program
- 02/07/23
- Dave & Buster's: Dave & Buster's World opens virtual doors on Roblox
- 12/06/22
- Dave & Buster's provides Q4 business update
- 03/27/23
- Nano Dimension files lawsuit against Murchinson, Anson and Boothbay
- 03/27/23
- Nano Dimension announces purchase order from Fraunhofer Institue
- 02/28/23
- nCino selected by JFG to modernize multiple lines of business
- 02/22/23
- nCino's SimpleNexus announces Avidia Bank implemented Nexus Closing
- 02/13/23
- nCino says DOJ investigation closed, no fines or penalties imposed
- 02/07/23
- nCino expands nCino IQ offerings through partnership with rich data company
- 03/28/23
- Micron says now expects overall headcount reduction to approach 15%
- 03/28/23
- Micron says further reducing supply
- 03/28/23
- Micron up 2% after Q2 report
- 03/02/23
- Micron down 3% in pre-market as CFO presents at conference
- 03/29/23
- Macy's announces CFO Adrian Mitchell to assume COO role as well
- 03/29/23
- Macy's CEO Jeff Gennette to retire, Tony Spring to succeed
- 03/14/23
- Macy's launches expanded Reebok assortment in stores, online
- 03/02/23
- Macy's rises 10.0%
- 03/27/23
- Lyft announces CEO succession plan, appoints David Risher next CEO
- 03/14/23
- California court upholds treating Uber, Lyft drivers as contractors
- 02/16/23
- Lyft announces Alicia Zuiker joining as Chief People Officer
- 02/09/23
- Lyft says focus on growth will be centered around Pink
- 12/29/22
- Kingsoft Cloud announces results of extraordinary general meeting
- 12/27/22
- China stocks rising with borders set to reopen on January 8
- 12/23/22
- PCAOB chair 'applauds' Congressional action to shorten HFCAA timeline
- 03/26/23
- Fly Intel: Top five weekend stock stories
- 03/22/23
- JPMorgan to acquire Aumni, terms not disclosed
- 03/21/23
- Campbell Lutyens and J.P. Morgan announce collaboration in 2NDRY advisory market
- 03/24/23
- Illumina says Icahn nominees 'lack relevant skills and experience'
- 03/24/23
- Icahn to investigate 'massive value destruction' by Illumina
- 03/20/23
- Illumina says Icahn's nominees 'lack relevant skills and experience'
- 03/15/23
- Icahn says 'only path forward' for Illumina is to divest GRAIL
- 02/21/23
- Bath & Body Works appoints Hershey CFO Voskuil to board
- 12/07/22
- Hershey announces first bilingual manufacturing facility
- 10/20/22
- Hershey signs new solar power purchase agreement with National Grid Renewables
- 03/27/23
- First Republic rises 15.5%
- 03/27/23
- First Republic rises 22.8%
- 03/27/23
- First Republic rises 25.0%
- 03/20/23
- Foot Locker focusing on banners, geographies that will drive growth, says CEO
- 03/20/23
- Foot Locker to close stores, ecommerce in Hong Kong, Macau
- 11/29/22
- Foot Locker announces leadership team appointments
- 11/18/22
- Foot Locker rises 14.7%
EBS Emergent BioSolutions - 03/29/23
- Emergent says over-the-counter Narcan will be available by late summer
- 03/29/23
- Emergent BioSolutions: FDA approves OTC designation for Narcan Nasal Spray
- 03/29/23
- Emergent BioSolutions rises 17.5%
- 03/29/23
- Emergent jumps 19% to $10.60 after FDA approves over-the-counter Narcan
- 03/05/23
- Fly Intel: Top five weekend stock stories
- 02/22/23
- Deere raises dividend to $1.25 from $1.20 per share
- 02/17/23
- Deere sees raw material costs getting more favorable throughout 2023
- 02/17/23
- Deere doesn't see big increase in dealier inventory in 2023
- 03/29/23
- UBS board names Sergio Ermotti as new group CEO, effective April 5
- 03/27/23
- Invesco Mortgage says no direct counterparty exposure to Credit Suisse
- 03/21/23
- Chubb says does not have exposure to any Credit Suisse AT1 bonds
- 03/20/23
- S&P revises UBS Group outlook to Negative, affirms ratings
- 03/29/23
- Conn's down 1% to $5.35 as earnings call continues
- 03/29/23
- Conn's CEO says total retail sales down 18.6% in Q1-to-date
- 03/29/23
- Conn's plans to open 11 new standalone locations in FY24
- 01/10/23
- Conn's extending gains afterhours on WSJ report of acquisition interest, up 13%
- 03/06/23
- Ciena expects to repurchase $250M shares this FY
- 03/06/23
- Ciena sees inventory lower in 4Q23 vs. 4Q22
- 03/06/23
- Ciena on track to achieve three year revenue CAGR outlook of 10%-12%, says CEO
- 03/06/23
- Ciena CEO: WaveLogic 6 to support up to 1.6Tbps single carrier wavelengths
- 03/27/23
- Carnival CEO says 'well booked for the remainder of the year at higher prices'
- 03/27/23
- Carnival ends Q1 with $8.1B of liquidity
- 01/27/23
- Salesforce appoints three new independent directors to board
- 01/18/23
- Carnival expands next-generation wi-fi connectivity with SpaceX's Starlink
- 03/28/23
- Cal-Maine Foods says current HPAI epidemic surpassed prior outbreak in duration
- 03/27/23
- Cal-Maine Foods names Todd Walters COO
- 02/06/23
- Reed asked FTC to crack down on possible egg price gouging
- 01/19/23
- Cal-Maine Foods in partnership with Entegrity to install solar array
- 03/06/23
- Cardinal Health, Signify Health collaborate on in-home health management
- 02/16/23
- Cardinal Health, RxLive collaborate to enhance connectivity between providers
- 12/19/22
- Cardinal Health announces Aaron Alt as chief financial officer
- 12/12/22
- Yellow Corp appoints Annlea Rumfola as CIO
- 11/22/22
- Burlington Stores rises 14.5%
- 11/22/22
- Burlington Stores rises 16.8%
- 11/22/22
- Burlington Stores rises 17.0%
- 11/22/22
- Burlington Stores CEO: 'We think the outlook for 2023 is very positive'
- 01/18/23
- Bluebird Bio falls 14% to $6.28 after 20M share offering of common stock
- 01/06/23
- Bluebird Bio to sell second Zynteglo PRV for $95M
- 01/03/23
- Bluebird Bio appoints Joseph Vittiglio, JD, chief business and legal officer
- 12/29/22
- Bluebird Bio completes sale pf PRV to Argenx
ARCT Arcturus Therapeutics - 03/29/23
- Arcturus Therapeutics says cash runway now extends to 2026
- 01/31/23
- Arcturus: New Zealand approves clinical trial application for ARCT-032 for CF
- 12/12/22
- CSL announces closing of global collaboration with Arcturus Therapeutics
- 11/01/22
- Arcturus Therapeutics announces collaboration with CSL Seqirus
- 03/29/23 Needham
- Micron price target raised to $71 from $67 at Needham
- 03/29/23 Susquehanna
- Micron price target raised to $90 from $65 at Susquehanna
- 03/29/23 TD Cowen
- Micron price target raised to $70 from $66 at TD Cowen
- 03/29/23 Baird
- Micron price target raised to $60 from $45 at Baird
- 03/29/23
- Gordon Haskett downgrades Macy's on moderating foot traffic trends
- 03/29/23
- Macy's downgraded to Hold from Accumulate at Gordon Haskett
- 03/03/23 TD Cowen
- Macy's price target raised to $29 from $27 at TD Cowen
- 02/23/23 Citi
- Macy's price target raised to $23 from $22 at Citi
- 03/29/23 RBC Capital
- Sunrun price target lowered to $34 from $42 at RBC Capital
- 03/24/23 Jefferies
- UBS downgraded to Hold from Buy at Jefferies
- 03/20/23 Barclays
- European Banks sector view downgraded to Neutral at Barclays
- 03/20/23 Societe Generale
- UBS downgraded to Hold from Buy at Societe Generale
- 03/29/23 RBC Capital
- UBS downgraded to Sector Perform from Outperform at RBC Capital
- 03/27/23 Citi
- UBS price target raised to CHF 26 from CHF 24 at Citi
- 03/26/23 Citi
- UBS price target raised to CHF 26 from CHF 24 at Citi
- 03/10/23 Lake Street
- Nano Dimension made 'lowball offer' Stratasys won't accept, says Lake Street
- 03/03/23 Lake Street
- Stratasys price target raised to $22 from $20 at Lake Street
- 01/04/23 Needham
- Needham upgrades Stratasys to Buy, sees valuation reflect more challenging 2023
- 01/04/23 Needham
- Stratasys upgraded to Buy from Hold at Needham
- 03/22/23 Deutsche Bank
- Cardinal Health price target lowered to $77 from $82 at Deutsche Bank
- 02/03/23 Baird
- Baird upgrades Cardinal Health, sees 'value trap label' ending
- 02/03/23 Baird
- Cardinal Health upgraded to Outperform from Neutral at Baird
- 01/31/23 UBS
- Cardinal Health price target raised to $91 from $78 at UBS
- 03/13/23 Piper Sandler
- Piper agrees with Icahn, says Illumina base business undervalued
- 02/14/23 UBS
- Illumina price target lowered to $240 from $255 at UBS
- 02/08/23 Stifel
- Illumina price target lowered to $235 from $285 at Stifel
- 02/08/23 RBC Capital
- Illumina price target raised to $303 from $284 at RBC Capital
- 03/28/23 Deutsche Bank
- Lyft CEO change 'opens the door' for potential buyout, says Deutsche Bank
- 03/28/23 Wedbush
- Wedbush incrementally more positive on Lyft with 'CEO changing of guard'
- 03/15/23 Deutsche Bank
- Lyft price target raised to $12 from $11 at Deutsche Bank
- 03/14/23 Jefferies
- California ruling a 'big win' for Uber, Lyft and DoorDash, says Jefferies
- 03/24/23 RBC Capital
- JPMorgan price target lowered to $132 from $150 at RBC Capital
- 03/13/23 Wells Fargo
- Wells Fargo upgrades JPMorgan on 'Goliath is Winning' theme
- 03/13/23 Wells Fargo
- JPMorgan upgraded to Overweight from Equal Weight at Wells Fargo
- 02/24/23 Morgan Stanley
- JPMorgan price target raised to $173 from $167 at Morgan Stanley
- 03/23/23 Citi
- Citi withdraws Neutral rating on First Republic
- 03/21/23 Goldman Sachs
- First Republic rating suspended at Goldman Sachs
- 03/20/23 Evercore ISI
- Evercore ISI suspends rating on First Republic in light of uncertainty
- 03/20/23 Morgan Stanley
- Morgan Stanley removes First Republic price target amid 'wide range of outcomes'
ARCT Arcturus Therapeutics - 11/14/22 Wells Fargo
- Arcturus Therapeutics resumed with an Overweight at Wells Fargo
- 11/10/22 Baird
- Arcturus Therapeutics downgraded to Underperform from Neutral at Baird
- 11/03/22 Citi
- Arcturus Therapeutics upgraded to Buy at Citi after CSL deal
- 11/03/22 Citi
- Arcturus Therapeutics upgraded to Buy from Neutral at Citi
EBS Emergent BioSolutions - 03/17/23 JPMorgan
- Emergent BioSolutions downgraded to Underweight from Neutral at JPMorgan
- 12/28/22 Benchmark
- Benchmark keeps Hold on Emergent after non-profit OTC naloxone competitor news
- 11/10/22 Benchmark
- Benchmark downgrades Emergent on delay in smallpox vaccine fulfillment
- 11/10/22 Benchmark
- Emergent BioSolutions downgraded to Hold from Buy at Benchmark
- 03/13/23 JPMorgan
- Kingsoft Cloud initiated with a Neutral at JPMorgan
- 01/09/23 China Renaissance
- Kingsoft Cloud downgraded to Sell from Hold at China Renaissance
- 09/07/22 Citi
- Kingsoft Cloud downgraded to Neutral from Buy at Citi
- 06/09/22 Citi
- Kingsoft Cloud price target lowered to $8.50 from $10 at Citi
- 03/29/23 Raymond James
- Bluebird Bio reaction to lovo-cel BLA delay 'overdone,' says Raymond James
- 03/06/23 Baird
- Baird starts Bluebird at Outperform, sees lovo-cel beating estimates
- 03/06/23 Baird
- Bluebird Bio initiated with an Outperform at Baird
- 12/19/22 Morgan Stanley
- FDA removing lovo-cel partial hold a positive for Bluebird, says Morgan Stanley
- 01/03/23 BTIG
- Sharecare named Top Pick for first half of 2023 at BTIG
- 11/11/22 Canaccord
- Sharecare price target lowered to $3 from $4 at Canaccord
- 11/11/22 Canaccord
- Sharecare price target lowered to $3 from $4 at Canaccord
- 10/19/22 BTIG
- Sharecare 'obvious beneficiary' of Elevance growth, says BTIG
- 03/29/23 Canaccord
- SomaLogic price target lowered to $5 from $6 at Canaccord
- 03/29/23 TD Cowen
- SomaLogic price target lowered to $7 from $8 at TD Cowen
- 03/29/23 Stifel
- SomaLogic price target lowered to $7 from $8 at Stifel
- 08/16/22 TD Cowen
- SomaLogic price target lowered to $9 from $11 at Cowen
- 03/29/23 Susquehanna
- Susquehanna upgrades Carnival with liquidity concerns 'effectively de-risked'
- 03/29/23 Susquehanna
- Carnival upgraded to Positive from Neutral at Susquehanna
- 03/28/23 Stifel
- Stifel believes setup for Carnival's shares is 'overly compelling'
- 03/28/23 Barclays
- Carnival price target raised to $13 from $12 at Barclays
- 03/29/23 Wells Fargo
- Hershey upgraded to Equal Weight on pricing tailwinds at Wells Fargo
- 03/29/23 Wells Fargo
- Hershey upgraded to Equal Weight from Underweight at Wells Fargo
- 03/27/23 Mizuho
- Hershey price target raised to $235 from $222 at Mizuho
- 03/23/23 Evercore ISI
- Hershey price target raised to $255 from $250 at Evercore ISI
- 03/29/23 UBS
- Foot Locker downgraded to Sell at UBS on softlines bearishness
- 03/29/23 UBS
- Foot Locker downgraded to Sell from Neutral at UBS
- 03/21/23 Deutsche Bank
- Foot Locker price target raised to $42 from $36 at Deutsche Bank
- 03/21/23 Morgan Stanley
- Morgan Stanley 'skeptical' of 'show-me' story Foot Locker's long-term targets
- 03/29/23 UBS
- Urban Outfitters downgraded to Sell at UBS on softlines bearishness
- 03/29/23 UBS
- Urban Outfitters downgraded to Sell from Neutral at UBS
- 03/02/23 Barclays
- Urban Outfitters price target raised to $29 from $27 at Barclays
- 03/01/23 Deutsche Bank
- Deutsche Bank keeps Hold rating on Urban Outfitters, raises price target to $27
- 03/29/23 UBS
- Burlington Stores downgraded to Sell at UBS on softlines bearishness
- 03/29/23 UBS
- Burlington Stores downgraded to Sell from Neutral at UBS
- 03/03/23 Deutsche Bank
- Burlington Stores price target raised to $235 from $214 at Deutsche Bank
- 03/03/23 Morgan Stanley
- Burlington Stores price target raised to $233 from $219 at Morgan Stanley
- 03/29/23 UBS
- Ross Stores downgraded to Sell at UBS on softlines bearishness
- 03/29/23 UBS
- Ross Stores downgraded to Sell from Neutral at UBS
- 03/22/23 Loop Capital
- Loop upgrades Ross Stores to Buy on steady spending, conservative outlook
- 03/22/23 Loop Capital
- Ross Stores upgraded to Buy from Hold at Loop Capital
- 03/29/23 Morgan Stanley
- Ciena downgraded to Equal Weight from Overweight at Morgan Stanley
- 03/28/23 Raymond James
- Ciena added to Analyst Current Favorites List at Raymond James
- 03/28/23 Raymond James
- Ciena upgraded to Strong Buy from Outperform at Raymond James
- 03/07/23 B. Riley
- Ciena price target raised to $72 from $69 at B. Riley
- 03/29/23 Daiwa
- Deere initiated with an Outperform at Daiwa
- 03/29/23 Daiwa
- Deere initiated with an Outperform at Daiwa
- 02/21/23 Argus
- Deere price target raised to $485 from $475 at Argus
- 02/21/23 Morgan Stanley
- Deere price target raised to $537 from $522 at Morgan Stanley
- 03/24/23 Lake Street
- Vital Farms initiated with a Buy at Lake Street
- 12/29/22 BofA
- Cal-Maine earnings miss to weigh on shares, says BofA
- 09/28/22 BofA
- Cal-Maine Foods price target lowered to $50 from $55 at BofA
- 03/30/22 Consumer Edge
- Cal-Maine Foods upgraded to Overweight from Equal Weight at Consumer Edge
- 03/29/23 Stephens
- nCino price target lowered to $27 from $33 at Stephens
- 03/29/23 Needham
- nCino price target lowered to $33 from $35 at Needham
- 03/29/23 Truist
- nCino price target lowered to $40 from $45 at Truist
- 03/29/23 BofA
- nCino price target lowered to $30 from $32 at BofA
- 03/29/23 Truist
- Dave & Buster's price target lowered to $60 from $62 at Truist
- 03/14/23 Truist
- Truist card transaction data bullish for fast-food restaurant demand
- 12/21/22 Jefferies
- Brinker downgraded to Hold from Buy at Jefferies
- 12/08/22 Loop Capital
- Dave & Buster's off to slow start in Q4, says Loop Capital
- 03/29/23 Oppenheimer
- Progress Software price target raised to $63 from $53 at Oppenheimer
- 03/13/23 Guggenheim
- Progress Software price target raised to $64 from $60 at Guggenheim
- 03/12/23 Citi
- Citi not too concerned about systems software exposure to SVB
- 01/23/23 Guggenheim
- Progress Software assumed with a Buy at Guggenheim
- 12/07/22 Stephens
- Conn's price target lowered to $9 from $13 at Stephens
- 04/11/22 Stephens
- Conn's assumed with an Equal Weight at Stephens
- 02/28/23
- Urban Outfitters reports Q4 EPS 34c, consensus 38c
- 11/21/22
- Urban Outfitters reports Q3 EPS 40c, consensus 42c
- 11/21/22
- Notable companies reporting after market close
- 01/31/23
- UBS reports Q4 EPS 50c, profit before tax $1.9B
- 10/25/22
- UBS reports Q3 EPS 52c, net profit $1.7B
- 03/02/23
- Stratasys sees FY23 EPS 12c-24c, consensus 20c
- 03/02/23
- Stratasys reports Q4 EPS 7c, consensus 3c
- 11/10/22
- Stratasys sees FY22 EPS 9c-12c, consensus 14c
- 03/28/23
- SomaLogic sees FY23 revenue $80M-$84M, consensus $92.75M
- 03/28/23
- SomaLogic reports Q4 EPS (26c), consensus (21c)
- 01/09/23
- SomaLogic sees 2022 revenue at high-end of $93M-$98M, consensus $95M
- 11/14/22
- SomaLogic sees FY22 revenue $93M-$98M, consensus $83.02M
- 03/29/23
- Sharecare sees FY23 revenue $450M-$460M, consensus $518.49M
- 03/29/23
- Sharecare sees Q1 revenue $111M-$113M, consensus $118.8M
- 03/29/23
- Sharecare reports Q4 adjusted EPS (2c), consensus (5c)
- 11/10/22
- Sharecare reports Q3 adjusted EPS (1c), consensus (6c)
- 02/28/23
- Ross Stores sees FY23 EPS $4.65-$4.95, consensus $5.09
- 02/28/23
- Ross Stores sees Q1 EPS 99c-$1.05, consensus $1.18
- 02/28/23
- Ross Stores reports Q4 EPS $1.31, consensus $1.24
- 02/28/23
- Notable companies reporting after market close
- 03/28/23
- Progress Software sees Q2 EPS 88c-92c, consensus 99c
- 03/28/23
- Progress Software backs FY23 EPS view $4.09-$4.17, consensus $4.14
- 03/28/23
- Progress Software reports Q1 EPS $1.19, consensus $1.05
- 01/17/23
- Progress Software sees FY23 EPS $4.09 - $4.17 , consensus $4.35
- 03/28/23
- Dave & Buster's reports Q4 EPS 80c, consensus 73c
- 12/06/22
- Dave & Buster's reports Q3 EPS 4c, consensus 4c
- 01/24/23
- Nano Dimension reports Q4 revenue $12.1M, up 61% vs. 4Q21
- 12/01/22
- Nano Dimension reports Q3 EPS (26c) vs. (7c) last year
- 10/24/22
- Nano Dimension sees Q3 revenue $10M
- 03/28/23
- nCino reports Q4 EPS 4c, consensus (5c)
- 01/19/23
- nCino backs FY23 EPS view of (15c)-(17c), consensus (16c)
- 01/19/23
- nCino backs Q4 EPS view of (4c)-(5c), consensus (5c)
- 11/30/22
- nCino raises FY23 EPS view to (17c)-(15c) from (19c)-(17c), consensus (17c)
- 03/28/23
- Micron sees Q3 adjusted EPS ($1.65)-($1.51), consensus (90c)
- 03/28/23
- Micron reports Q2 adjusted EPS ($1.91), consensus (86c)
- 03/28/23
- Notable companies reporting after market close
- 03/02/23
- Micron sees lower margins in fiscal Q3 than previously expected
- 03/02/23
- Macy's sees Q1 adjusted EPS 42c-48c, consensus 72c
- 03/02/23
- Macy's sees FY23 adjusted EPS $3.67-$4.11, consensus $3.84
- 03/02/23
- Macy's reports Q4 adjusted EPS $1.88, consensus $1.57
- 03/01/23
- Notable companies reporting before tomorrow's open
- 02/09/23
- Lyft reports Q4 active riders up 8.7% y/y
- 02/09/23
- Lyft sees Q1 revenue roughly $975M, consensus $1.09B
- 02/09/23
- Lyft reports Q4 adjusted EBITDA ($248.3M) vs ($47.6M) last year
- 02/09/23
- Notable companies reporting after market close
- 03/29/23
- Kingsoft Cloud sees Q1 revenue RMB1.85B-RMB2.05B
- 03/29/23
- Kingsoft Cloud reports Q4 EPS (2c), consensus (24c)
- 11/23/22
- Kingsoft Cloud sees Q4 revenue up 1.6%-11.7% sequentially to RMB2.0B-RMB2.2B
- 11/23/22
- Kingsoft Cloud reports Q3 EPS (3c), consensus (23c)
- 01/13/23
- JPMorgan reports Q4 EPS $3.57, consensus $3.07
- 01/12/23
- Notable companies reporting before tomorrow's open
- 10/14/22
- JPMorgan reports Q3 EPS $3.12, consensus $2.88
- 02/07/23
- Illumina sees FY23 adjusted EPS $1.25-$1.50, consensus $1.98
- 02/07/23
- Illumina reports Q4 adjusted EPS 14c, consensus 10c
- 02/07/23
- Notable companies reporting after market close
- 11/03/22
- Illumina sees FY22 adjusted EPS $2.35-$2.50, consensus $2.78
- 03/22/23
- Hershey backs FY23 adjusted EPS growth view 9%-11%, consensus $9.35
- 02/02/23
- Hershey sees FY23 adjusted EPS up 9%-11%, consensus $8.94
- 02/02/23
- Hershey reports Q4 adjusted EPS $2.02, consensus $1.77
- 01/13/23
- First Republic reports Q4 EPS $1.88, consensus $1.80
- 10/14/22
- First Republic reports Q3 EPS $2.21, consensus $2.18
- 03/20/23
- Foot Locker targeting adjusted EPS growth in low to mid 20% range for FY24-FY26
- 03/20/23
- Foot Locker sees FY23 adjusted EPS $3.35-$3.65, consensus $4.48
- 03/20/23
- Foot Locker reports Q4 adjusted EPS 97c, consensus 51c
- 11/18/22
- Foot Locker raises FY22 EPS view to $4.42-$4.50 from $4.25-$4.45
EBS Emergent BioSolutions - 02/27/23
- Emergent BioSolutions sees FY23 revenue $1.1B-$1.2B, consensus $1.18B
- 02/27/23
- Emergent BioSolutions sees Q1 revenue $130M-$150M, consensus $245.9M
- 02/27/23
- Emergent BioSolutions reports Q4 EPS (31c), consensus 4c
- 01/09/23
- Emergent reports preliminary FY22 revenue $1.1B-$1.12B, consensus $1.09B
- 02/17/23
- Deere sees FY23 net income $8.75B-$9.25B, effective tax rate 23%-25%
- 02/17/23
- Deere reports Q1 EPS $6.55, consensus $5.56
- 02/16/23
- Notable companies reporting before tomorrow's open
- 02/09/23
- Credit Suisse reports Q4 net revenue CHF 3.06B vs. CHF 4.58B last year
- 10/27/22
- Credit Suisse reports Q3 net revenue CHF 3.8B vs. CHF 5.43B last year
- 03/29/23
- Conn's reports Q4 adjusted EPS ($1.53), consensus (87c)
- 12/06/22
- Conn's reports Q3 non-GAAP EPS (78c), consensus (83c)
- 10/18/22
- Conn's withdraws FY23 financial guidance
- 10/18/22
- Conn's sees Q3 revenue down 21%-23%, consensus $326.11M
- 03/06/23
- Ciena now sees FY23 revenue up 20%-22% y/y, up from 16%-18% y/y
- 03/06/23
- Ciena sees Q2 revenue $1.035B-$1.115B, consensus $1.04B
- 03/06/23
- Ciena reports Q1 adjusted EPS 64c, consensus 36c
- 12/08/22
- Ciena sees Q1 revenue $910M-$990M, consensus $871.03M
- 03/27/23
- Carnival sees Q2 adjusted EBITDA $600M-$700M
- 03/27/23
- Carnival sees FY23 adjusted EBITDA $3.9B-$4.1B
- 03/27/23
- Carnival sees FY23 adjusted EPS (44c)-(28c), consensus (8c)
- 03/27/23
- Carnival sees Q2 adjusted EPS (42c)-(34c), consensus (28c)
- 03/28/23
- Cal-Maine Foods reports Q3 EPS $6.62, consensus $5.47
- 12/28/22
- Cal-Maine Foods reports Q2 EPS $4.07, consensus $4.24
- 02/02/23
- Cardinal Health raises FY23 EPS view to $5.20-$5.50 from $5.05-$5.40
- 02/02/23
- Cardinal Health reports Q2 EPS $1.32, consensus $1.14
- 02/01/23
- Notable companies reporting before tomorrow's open
- 03/02/23
- Burlington Stores sees Q1 adjusted EPS 85c-95c, consensus 82c
- 03/02/23
- Burlington Stores sees FY23 adjusted EPS $5.50-$6.00, consensus $6.65
- 03/02/23
- Burlington Stores reports Q4 adjusted EPS $2.96, consensus $2.73
- 03/29/23
- Bluebird Bio reports Q4 EPS (38c), consensus (44c)
- 11/07/22
- Bluebird Bio reports Q4 EPS (94c) vs, ($3.16)
- 11/07/22
- Bluebird Bio reports Q4 EPS (94c) vs, ($3.16)
ARCT Arcturus Therapeutics - 03/28/23
- Arcturus Therapeutics reports Q4 EPS $4.33, consensus 98c
- 11/09/22
- Arcturus Therapeutics reports Q3 EPS ($1.33), consensus ($1.81)
|
On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - 03/06/23
- Urban Outfitters COO Conforti sells 42,000 common shares
- 02/28/23
- Urban Outfitters says Q1 revenue growth could be 'similar to Q4'
- 02/28/23
- Urban Outfitters reports comparable retail segment sales up 3%
- 01/09/23
- Urban Outfitters reports holiday sales increased 2.3%
- 03/20/23
- UBS rises 7.9%
- 03/19/23
- Fly Intel: Top five weekend stock stories
- 03/29/23
- Nano Dimension increases offer to acquire Stratasys to $19.55 per share
- 03/23/23
- Nano Dimension to review options relative to Stratasys and alternative targets
- 03/22/23
- Stratasys up 4.5% at $15.25 as its board rejects Nano Dimension offer
- 03/22/23
- Stratasys board unanimously rejects acquisition proposal from Nano Dimension
- 03/13/23
- SomaLogic delivers 28M proteomic data points on CKB samples
- 01/05/23
- Cathie Wood's ARK Investment bought 415.4K shares of SomaLogic today
- 01/04/23
- Cathie Wood's ARK Investment bought 313K shares of SomaLogic today
- 01/03/23
- Cathie Wood's ARK Investment bought 288K shares of SomaLogic today
- 02/27/23
- Sharecare expands home offerings beyond Medicare Advantage
- 11/17/22
- Ross Stores jumps 15% to $112.50 after Q3 results beat, FY22 EPS view raised
- 11/14/22
- Soros Fund Management buys Sierra Wireless, exits Kinder Morgan in Q3
- 10/16/22
- Fly Intel: Top five weekend stock stories
- 03/23/23
- Progress Software offers free training, certification for Progress OpenEdge
- 02/07/23
- Progress Software completes acquisition of MarkLogic
- 01/19/23
- Progress Software releases Progress Telerik, Progress Kendo UI
- 01/03/23
- Progress Software to acquire MarkLogic for $355M
- 03/28/23
- Dave & Buster's says Q1 QTD SSS roughly flat to down very low single digits
- 03/28/23
- Dave & Buster's announces $100M share repurchase program
- 02/07/23
- Dave & Buster's: Dave & Buster's World opens virtual doors on Roblox
- 12/06/22
- Dave & Buster's provides Q4 business update
- 03/27/23
- Nano Dimension files lawsuit against Murchinson, Anson and Boothbay
- 03/27/23
- Nano Dimension announces purchase order from Fraunhofer Institue
- 02/28/23
- nCino selected by JFG to modernize multiple lines of business
- 02/22/23
- nCino's SimpleNexus announces Avidia Bank implemented Nexus Closing
- 02/13/23
- nCino says DOJ investigation closed, no fines or penalties imposed
- 02/07/23
- nCino expands nCino IQ offerings through partnership with rich data company
- 03/28/23
- Micron says now expects overall headcount reduction to approach 15%
- 03/28/23
- Micron says further reducing supply
- 03/28/23
- Micron up 2% after Q2 report
- 03/02/23
- Micron down 3% in pre-market as CFO presents at conference
- 03/29/23
- Macy's announces CFO Adrian Mitchell to assume COO role as well
- 03/29/23
- Macy's CEO Jeff Gennette to retire, Tony Spring to succeed
- 03/14/23
- Macy's launches expanded Reebok assortment in stores, online
- 03/02/23
- Macy's rises 10.0%
- 03/27/23
- Lyft announces CEO succession plan, appoints David Risher next CEO
- 03/14/23
- California court upholds treating Uber, Lyft drivers as contractors
- 02/16/23
- Lyft announces Alicia Zuiker joining as Chief People Officer
- 02/09/23
- Lyft says focus on growth will be centered around Pink
- 12/29/22
- Kingsoft Cloud announces results of extraordinary general meeting
- 12/27/22
- China stocks rising with borders set to reopen on January 8
- 12/23/22
- PCAOB chair 'applauds' Congressional action to shorten HFCAA timeline
- 03/26/23
- Fly Intel: Top five weekend stock stories
- 03/22/23
- JPMorgan to acquire Aumni, terms not disclosed
- 03/21/23
- Campbell Lutyens and J.P. Morgan announce collaboration in 2NDRY advisory market
- 03/24/23
- Illumina says Icahn nominees 'lack relevant skills and experience'
- 03/24/23
- Icahn to investigate 'massive value destruction' by Illumina
- 03/20/23
- Illumina says Icahn's nominees 'lack relevant skills and experience'
- 03/15/23
- Icahn says 'only path forward' for Illumina is to divest GRAIL
- 02/21/23
- Bath & Body Works appoints Hershey CFO Voskuil to board
- 12/07/22
- Hershey announces first bilingual manufacturing facility
- 10/20/22
- Hershey signs new solar power purchase agreement with National Grid Renewables
- 03/27/23
- First Republic rises 15.5%
- 03/27/23
- First Republic rises 22.8%
- 03/27/23
- First Republic rises 25.0%
- 03/20/23
- Foot Locker focusing on banners, geographies that will drive growth, says CEO
- 03/20/23
- Foot Locker to close stores, ecommerce in Hong Kong, Macau
- 11/29/22
- Foot Locker announces leadership team appointments
- 11/18/22
- Foot Locker rises 14.7%
- $13.40 /
+2.165 (+19.27%) - 03/29/23
- Enovix announces manufacturing partner, location for Fab-2 in Malaysia
- 03/20/23
- Enovix director buys $757K in common stock
- 03/15/23
- Enovix director buys $1.35M in common stock
- 03/13/23
- Enovix announces several leadership additions
- 03/05/23
- Fly Intel: Top five weekend stock stories
- 02/22/23
- Deere raises dividend to $1.25 from $1.20 per share
- 02/17/23
- Deere sees raw material costs getting more favorable throughout 2023
- 02/17/23
- Deere doesn't see big increase in dealier inventory in 2023
- 03/29/23
- UBS board names Sergio Ermotti as new group CEO, effective April 5
- 03/27/23
- Invesco Mortgage says no direct counterparty exposure to Credit Suisse
- 03/21/23
- Chubb says does not have exposure to any Credit Suisse AT1 bonds
- 03/20/23
- S&P revises UBS Group outlook to Negative, affirms ratings
- 03/29/23
- Conn's down 1% to $5.35 as earnings call continues
- 03/29/23
- Conn's CEO says total retail sales down 18.6% in Q1-to-date
- 03/29/23
- Conn's plans to open 11 new standalone locations in FY24
- 01/10/23
- Conn's extending gains afterhours on WSJ report of acquisition interest, up 13%
- 03/06/23
- Ciena expects to repurchase $250M shares this FY
- 03/06/23
- Ciena sees inventory lower in 4Q23 vs. 4Q22
- 03/06/23
- Ciena on track to achieve three year revenue CAGR outlook of 10%-12%, says CEO
- 03/06/23
- Ciena CEO: WaveLogic 6 to support up to 1.6Tbps single carrier wavelengths
- 03/27/23
- Carnival CEO says 'well booked for the remainder of the year at higher prices'
- 03/27/23
- Carnival ends Q1 with $8.1B of liquidity
- 01/27/23
- Salesforce appoints three new independent directors to board
- 01/18/23
- Carnival expands next-generation wi-fi connectivity with SpaceX's Starlink
- 03/28/23
- Cal-Maine Foods says current HPAI epidemic surpassed prior outbreak in duration
- 03/27/23
- Cal-Maine Foods names Todd Walters COO
- 02/06/23
- Reed asked FTC to crack down on possible egg price gouging
- 01/19/23
- Cal-Maine Foods in partnership with Entegrity to install solar array
- 03/06/23
- Cardinal Health, Signify Health collaborate on in-home health management
- 02/16/23
- Cardinal Health, RxLive collaborate to enhance connectivity between providers
- 12/19/22
- Cardinal Health announces Aaron Alt as chief financial officer
- 12/12/22
- Yellow Corp appoints Annlea Rumfola as CIO
- 11/22/22
- Burlington Stores rises 14.5%
- 11/22/22
- Burlington Stores rises 16.8%
- 11/22/22
- Burlington Stores rises 17.0%
- 11/22/22
- Burlington Stores CEO: 'We think the outlook for 2023 is very positive'
- 01/18/23
- Bluebird Bio falls 14% to $6.28 after 20M share offering of common stock
- 01/06/23
- Bluebird Bio to sell second Zynteglo PRV for $95M
- 01/03/23
- Bluebird Bio appoints Joseph Vittiglio, JD, chief business and legal officer
- 12/29/22
- Bluebird Bio completes sale pf PRV to Argenx
ARCT Arcturus Therapeutics - 03/29/23
- Arcturus Therapeutics says cash runway now extends to 2026
- 01/31/23
- Arcturus: New Zealand approves clinical trial application for ARCT-032 for CF
- 12/12/22
- CSL announces closing of global collaboration with Arcturus Therapeutics
- 11/01/22
- Arcturus Therapeutics announces collaboration with CSL Seqirus
- 03/29/23 Needham
- Micron price target raised to $71 from $67 at Needham
- 03/29/23 Susquehanna
- Micron price target raised to $90 from $65 at Susquehanna
- 03/29/23 TD Cowen
- Micron price target raised to $70 from $66 at TD Cowen
- 03/29/23 Baird
- Micron price target raised to $60 from $45 at Baird
- 03/29/23
- Gordon Haskett downgrades Macy's on moderating foot traffic trends
- 03/29/23
- Macy's downgraded to Hold from Accumulate at Gordon Haskett
- 03/03/23 TD Cowen
- Macy's price target raised to $29 from $27 at TD Cowen
- 02/23/23 Citi
- Macy's price target raised to $23 from $22 at Citi
- 03/29/23 RBC Capital
- Sunrun price target lowered to $34 from $42 at RBC Capital
- 03/24/23 Jefferies
- UBS downgraded to Hold from Buy at Jefferies
- 03/20/23 Barclays
- European Banks sector view downgraded to Neutral at Barclays
- 03/20/23 Societe Generale
- UBS downgraded to Hold from Buy at Societe Generale
- 03/29/23 RBC Capital
- UBS downgraded to Sector Perform from Outperform at RBC Capital
- 03/27/23 Citi
- UBS price target raised to CHF 26 from CHF 24 at Citi
- 03/26/23 Citi
- UBS price target raised to CHF 26 from CHF 24 at Citi
- 03/10/23 Lake Street
- Nano Dimension made 'lowball offer' Stratasys won't accept, says Lake Street
- 03/03/23 Lake Street
- Stratasys price target raised to $22 from $20 at Lake Street
- 01/04/23 Needham
- Needham upgrades Stratasys to Buy, sees valuation reflect more challenging 2023
- 01/04/23 Needham
- Stratasys upgraded to Buy from Hold at Needham
- 03/22/23 Deutsche Bank
- Cardinal Health price target lowered to $77 from $82 at Deutsche Bank
- 02/03/23 Baird
- Baird upgrades Cardinal Health, sees 'value trap label' ending
- 02/03/23 Baird
- Cardinal Health upgraded to Outperform from Neutral at Baird
- 01/31/23 UBS
- Cardinal Health price target raised to $91 from $78 at UBS
- 03/13/23 Piper Sandler
- Piper agrees with Icahn, says Illumina base business undervalued
- 02/14/23 UBS
- Illumina price target lowered to $240 from $255 at UBS
- 02/08/23 Stifel
- Illumina price target lowered to $235 from $285 at Stifel
- 02/08/23 RBC Capital
- Illumina price target raised to $303 from $284 at RBC Capital
- 03/28/23 Deutsche Bank
- Lyft CEO change 'opens the door' for potential buyout, says Deutsche Bank
- 03/28/23 Wedbush
- Wedbush incrementally more positive on Lyft with 'CEO changing of guard'
- 03/15/23 Deutsche Bank
- Lyft price target raised to $12 from $11 at Deutsche Bank
- 03/14/23 Jefferies
- California ruling a 'big win' for Uber, Lyft and DoorDash, says Jefferies
- 03/24/23 RBC Capital
- JPMorgan price target lowered to $132 from $150 at RBC Capital
- 03/13/23 Wells Fargo
- Wells Fargo upgrades JPMorgan on 'Goliath is Winning' theme
- 03/13/23 Wells Fargo
- JPMorgan upgraded to Overweight from Equal Weight at Wells Fargo
- 02/24/23 Morgan Stanley
- JPMorgan price target raised to $173 from $167 at Morgan Stanley
- 03/23/23 Citi
- Citi withdraws Neutral rating on First Republic
- 03/21/23 Goldman Sachs
- First Republic rating suspended at Goldman Sachs
- 03/20/23 Evercore ISI
- Evercore ISI suspends rating on First Republic in light of uncertainty
- 03/20/23 Morgan Stanley
- Morgan Stanley removes First Republic price target amid 'wide range of outcomes'
ARCT Arcturus Therapeutics - 11/14/22 Wells Fargo
- Arcturus Therapeutics resumed with an Overweight at Wells Fargo
- 11/10/22 Baird
- Arcturus Therapeutics downgraded to Underperform from Neutral at Baird
- 11/03/22 Citi
- Arcturus Therapeutics upgraded to Buy at Citi after CSL deal
- 11/03/22 Citi
- Arcturus Therapeutics upgraded to Buy from Neutral at Citi
- $13.40 /
+2.165 (+19.27%) - 02/23/23 Craig-Hallum
- Enovix price target lowered to $15 from $23 at Craig-Hallum
- 02/23/23 Piper Sandler
- Enovix price target raised to $25 from $22.50 at Piper Sandler
- 01/26/23 JPMorgan
- Enovix price target lowered to $16 from $28 at JPMorgan
- 01/23/23 Piper Sandler
- Enovix price target lowered to $22.50 from $26.50 at Piper Sandler
- 03/13/23 JPMorgan
- Kingsoft Cloud initiated with a Neutral at JPMorgan
- 01/09/23 China Renaissance
- Kingsoft Cloud downgraded to Sell from Hold at China Renaissance
- 09/07/22 Citi
- Kingsoft Cloud downgraded to Neutral from Buy at Citi
- 06/09/22 Citi
- Kingsoft Cloud price target lowered to $8.50 from $10 at Citi
- 03/06/23 Baird
- Baird starts Bluebird at Outperform, sees lovo-cel beating estimates
- 03/06/23 Baird
- Bluebird Bio initiated with an Outperform at Baird
- 12/19/22 Morgan Stanley
- FDA removing lovo-cel partial hold a positive for Bluebird, says Morgan Stanley
- 09/27/22 Morgan Stanley
- Vertex exa-cel filing timeline 'better than feared,' says Morgan Stanley
- 01/03/23 BTIG
- Sharecare named Top Pick for first half of 2023 at BTIG
- 11/11/22 Canaccord
- Sharecare price target lowered to $3 from $4 at Canaccord
- 11/11/22 Canaccord
- Sharecare price target lowered to $3 from $4 at Canaccord
- 10/19/22 BTIG
- Sharecare 'obvious beneficiary' of Elevance growth, says BTIG
- 03/29/23 Canaccord
- SomaLogic price target lowered to $5 from $6 at Canaccord
- 03/29/23 TD Cowen
- SomaLogic price target lowered to $7 from $8 at TD Cowen
- 03/29/23 Stifel
- SomaLogic price target lowered to $7 from $8 at Stifel
- 08/16/22 TD Cowen
- SomaLogic price target lowered to $9 from $11 at Cowen
- 03/29/23 Susquehanna
- Susquehanna upgrades Carnival with liquidity concerns 'effectively de-risked'
- 03/29/23 Susquehanna
- Carnival upgraded to Positive from Neutral at Susquehanna
- 03/28/23 Stifel
- Stifel believes setup for Carnival's shares is 'overly compelling'
- 03/28/23 Barclays
- Carnival price target raised to $13 from $12 at Barclays
- 03/29/23 Wells Fargo
- Hershey upgraded to Equal Weight on pricing tailwinds at Wells Fargo
- 03/29/23 Wells Fargo
- Hershey upgraded to Equal Weight from Underweight at Wells Fargo
- 03/27/23 Mizuho
- Hershey price target raised to $235 from $222 at Mizuho
- 03/23/23 Evercore ISI
- Hershey price target raised to $255 from $250 at Evercore ISI
- 03/29/23 UBS
- Foot Locker downgraded to Sell at UBS on softlines bearishness
- 03/29/23 UBS
- Foot Locker downgraded to Sell from Neutral at UBS
- 03/21/23 Deutsche Bank
- Foot Locker price target raised to $42 from $36 at Deutsche Bank
- 03/21/23 Morgan Stanley
- Morgan Stanley 'skeptical' of 'show-me' story Foot Locker's long-term targets
- 03/29/23 UBS
- Urban Outfitters downgraded to Sell at UBS on softlines bearishness
- 03/29/23 UBS
- Urban Outfitters downgraded to Sell from Neutral at UBS
- 03/02/23 Barclays
- Urban Outfitters price target raised to $29 from $27 at Barclays
- 03/01/23 Deutsche Bank
- Deutsche Bank keeps Hold rating on Urban Outfitters, raises price target to $27
- 03/29/23 UBS
- Burlington Stores downgraded to Sell at UBS on softlines bearishness
- 03/29/23 UBS
- Burlington Stores downgraded to Sell from Neutral at UBS
- 03/03/23 Deutsche Bank
- Burlington Stores price target raised to $235 from $214 at Deutsche Bank
- 03/03/23 Morgan Stanley
- Burlington Stores price target raised to $233 from $219 at Morgan Stanley
- 03/29/23 UBS
- Ross Stores downgraded to Sell at UBS on softlines bearishness
- 03/29/23 UBS
- Ross Stores downgraded to Sell from Neutral at UBS
- 03/22/23 Loop Capital
- Loop upgrades Ross Stores to Buy on steady spending, conservative outlook
- 03/22/23 Loop Capital
- Ross Stores upgraded to Buy from Hold at Loop Capital
- 03/29/23 Morgan Stanley
- Ciena downgraded to Equal Weight from Overweight at Morgan Stanley
- 03/28/23 Raymond James
- Ciena added to Analyst Current Favorites List at Raymond James
- 03/28/23 Raymond James
- Ciena upgraded to Strong Buy from Outperform at Raymond James
- 03/07/23 B. Riley
- Ciena price target raised to $72 from $69 at B. Riley
- 03/29/23 Daiwa
- Deere initiated with an Outperform at Daiwa
- 03/29/23 Daiwa
- Deere initiated with an Outperform at Daiwa
- 02/21/23 Argus
- Deere price target raised to $485 from $475 at Argus
- 02/21/23 Morgan Stanley
- Deere price target raised to $537 from $522 at Morgan Stanley
- 03/24/23 Lake Street
- Vital Farms initiated with a Buy at Lake Street
- 12/29/22 BofA
- Cal-Maine earnings miss to weigh on shares, says BofA
- 09/28/22 BofA
- Cal-Maine Foods price target lowered to $50 from $55 at BofA
- 03/30/22 Consumer Edge
- Cal-Maine Foods upgraded to Overweight from Equal Weight at Consumer Edge
- 03/29/23 Stephens
- nCino price target lowered to $27 from $33 at Stephens
- 03/29/23 Needham
- nCino price target lowered to $33 from $35 at Needham
- 03/29/23 Truist
- nCino price target lowered to $40 from $45 at Truist
- 03/29/23 BofA
- nCino price target lowered to $30 from $32 at BofA
- 03/29/23 Truist
- Dave & Buster's price target lowered to $60 from $62 at Truist
- 03/14/23 Truist
- Truist card transaction data bullish for fast-food restaurant demand
- 12/21/22 Jefferies
- Brinker downgraded to Hold from Buy at Jefferies
- 12/08/22 Loop Capital
- Dave & Buster's off to slow start in Q4, says Loop Capital
- 03/29/23 Oppenheimer
- Progress Software price target raised to $63 from $53 at Oppenheimer
- 03/13/23 Guggenheim
- Progress Software price target raised to $64 from $60 at Guggenheim
- 03/12/23 Citi
- Citi not too concerned about systems software exposure to SVB
- 01/23/23 Guggenheim
- Progress Software assumed with a Buy at Guggenheim
- 12/07/22 Stephens
- Conn's price target lowered to $9 from $13 at Stephens
- 04/11/22 Stephens
- Conn's assumed with an Equal Weight at Stephens
- 02/28/23
- Urban Outfitters reports Q4 EPS 34c, consensus 38c
- 11/21/22
- Urban Outfitters reports Q3 EPS 40c, consensus 42c
- 11/21/22
- Notable companies reporting after market close
- 01/31/23
- UBS reports Q4 EPS 50c, profit before tax $1.9B
- 10/25/22
- UBS reports Q3 EPS 52c, net profit $1.7B
- 03/02/23
- Stratasys sees FY23 EPS 12c-24c, consensus 20c
- 03/02/23
- Stratasys reports Q4 EPS 7c, consensus 3c
- 11/10/22
- Stratasys sees FY22 EPS 9c-12c, consensus 14c
- 03/28/23
- SomaLogic sees FY23 revenue $80M-$84M, consensus $92.75M
- 03/28/23
- SomaLogic reports Q4 EPS (26c), consensus (21c)
- 01/09/23
- SomaLogic sees 2022 revenue at high-end of $93M-$98M, consensus $95M
- 11/14/22
- SomaLogic sees FY22 revenue $93M-$98M, consensus $83.02M
- 03/29/23
- Sharecare sees FY23 revenue $450M-$460M, consensus $518.49M
- 03/29/23
- Sharecare sees Q1 revenue $111M-$113M, consensus $118.8M
- 03/29/23
- Sharecare reports Q4 adjusted EPS (2c), consensus (5c)
- 11/10/22
- Sharecare reports Q3 adjusted EPS (1c), consensus (6c)
- 02/28/23
- Ross Stores sees FY23 EPS $4.65-$4.95, consensus $5.09
- 02/28/23
- Ross Stores sees Q1 EPS 99c-$1.05, consensus $1.18
- 02/28/23
- Ross Stores reports Q4 EPS $1.31, consensus $1.24
- 02/28/23
- Notable companies reporting after market close
- 03/28/23
- Progress Software sees Q2 EPS 88c-92c, consensus 99c
- 03/28/23
- Progress Software backs FY23 EPS view $4.09-$4.17, consensus $4.14
- 03/28/23
- Progress Software reports Q1 EPS $1.19, consensus $1.05
- 01/17/23
- Progress Software sees FY23 EPS $4.09 - $4.17 , consensus $4.35
- 03/28/23
- Dave & Buster's reports Q4 EPS 80c, consensus 73c
- 12/06/22
- Dave & Buster's reports Q3 EPS 4c, consensus 4c
- 01/24/23
- Nano Dimension reports Q4 revenue $12.1M, up 61% vs. 4Q21
- 12/01/22
- Nano Dimension reports Q3 EPS (26c) vs. (7c) last year
- 10/24/22
- Nano Dimension sees Q3 revenue $10M
- 03/28/23
- nCino reports Q4 EPS 4c, consensus (5c)
- 01/19/23
- nCino backs FY23 EPS view of (15c)-(17c), consensus (16c)
- 01/19/23
- nCino backs Q4 EPS view of (4c)-(5c), consensus (5c)
- 11/30/22
- nCino raises FY23 EPS view to (17c)-(15c) from (19c)-(17c), consensus (17c)
- 03/28/23
- Micron sees Q3 adjusted EPS ($1.65)-($1.51), consensus (90c)
- 03/28/23
- Micron reports Q2 adjusted EPS ($1.91), consensus (86c)
- 03/28/23
- Notable companies reporting after market close
- 03/02/23
- Micron sees lower margins in fiscal Q3 than previously expected
- 03/02/23
- Macy's sees Q1 adjusted EPS 42c-48c, consensus 72c
- 03/02/23
- Macy's sees FY23 adjusted EPS $3.67-$4.11, consensus $3.84
- 03/02/23
- Macy's reports Q4 adjusted EPS $1.88, consensus $1.57
- 03/01/23
- Notable companies reporting before tomorrow's open
- 02/09/23
- Lyft reports Q4 active riders up 8.7% y/y
- 02/09/23
- Lyft sees Q1 revenue roughly $975M, consensus $1.09B
- 02/09/23
- Lyft reports Q4 adjusted EBITDA ($248.3M) vs ($47.6M) last year
- 02/09/23
- Notable companies reporting after market close
- 03/29/23
- Kingsoft Cloud sees Q1 revenue RMB1.85B-RMB2.05B
- 03/29/23
- Kingsoft Cloud reports Q4 EPS (2c), consensus (24c)
- 11/23/22
- Kingsoft Cloud sees Q4 revenue up 1.6%-11.7% sequentially to RMB2.0B-RMB2.2B
- 11/23/22
- Kingsoft Cloud reports Q3 EPS (3c), consensus (23c)
- 01/13/23
- JPMorgan reports Q4 EPS $3.57, consensus $3.07
- 01/12/23
- Notable companies reporting before tomorrow's open
- 10/14/22
- JPMorgan reports Q3 EPS $3.12, consensus $2.88
- 02/07/23
- Illumina sees FY23 adjusted EPS $1.25-$1.50, consensus $1.98
- 02/07/23
- Illumina reports Q4 adjusted EPS 14c, consensus 10c
- 02/07/23
- Notable companies reporting after market close
- 11/03/22
- Illumina sees FY22 adjusted EPS $2.35-$2.50, consensus $2.78
- 03/22/23
- Hershey backs FY23 adjusted EPS growth view 9%-11%, consensus $9.35
- 02/02/23
- Hershey sees FY23 adjusted EPS up 9%-11%, consensus $8.94
- 02/02/23
- Hershey reports Q4 adjusted EPS $2.02, consensus $1.77
- 01/13/23
- First Republic reports Q4 EPS $1.88, consensus $1.80
- 10/14/22
- First Republic reports Q3 EPS $2.21, consensus $2.18
- 03/20/23
- Foot Locker targeting adjusted EPS growth in low to mid 20% range for FY24-FY26
- 03/20/23
- Foot Locker sees FY23 adjusted EPS $3.35-$3.65, consensus $4.48
- 03/20/23
- Foot Locker reports Q4 adjusted EPS 97c, consensus 51c
- 11/18/22
- Foot Locker raises FY22 EPS view to $4.42-$4.50 from $4.25-$4.45
- $13.40 /
+2.165 (+19.27%) - 02/22/23
- Enovix reports Q EPS (19c), consensus (16c)
- 11/01/22
- Enovix sees 2022 revenue $6M-$8M, consensus $6.62M
- 11/01/22
- Enovix reports Q3 EPS (53c), consensus (16c)
- 02/17/23
- Deere sees FY23 net income $8.75B-$9.25B, effective tax rate 23%-25%
- 02/17/23
- Deere reports Q1 EPS $6.55, consensus $5.56
- 02/16/23
- Notable companies reporting before tomorrow's open
- 02/09/23
- Credit Suisse reports Q4 net revenue CHF 3.06B vs. CHF 4.58B last year
- 10/27/22
- Credit Suisse reports Q3 net revenue CHF 3.8B vs. CHF 5.43B last year
- 03/29/23
- Conn's reports Q4 adjusted EPS ($1.53), consensus (87c)
- 12/06/22
- Conn's reports Q3 non-GAAP EPS (78c), consensus (83c)
- 10/18/22
- Conn's withdraws FY23 financial guidance
- 10/18/22
- Conn's sees Q3 revenue down 21%-23%, consensus $326.11M
- 03/06/23
- Ciena now sees FY23 revenue up 20%-22% y/y, up from 16%-18% y/y
- 03/06/23
- Ciena sees Q2 revenue $1.035B-$1.115B, consensus $1.04B
- 03/06/23
- Ciena reports Q1 adjusted EPS 64c, consensus 36c
- 12/08/22
- Ciena sees Q1 revenue $910M-$990M, consensus $871.03M
- 03/27/23
- Carnival sees Q2 adjusted EBITDA $600M-$700M
- 03/27/23
- Carnival sees FY23 adjusted EBITDA $3.9B-$4.1B
- 03/27/23
- Carnival sees FY23 adjusted EPS (44c)-(28c), consensus (8c)
- 03/27/23
- Carnival sees Q2 adjusted EPS (42c)-(34c), consensus (28c)
- 03/28/23
- Cal-Maine Foods reports Q3 EPS $6.62, consensus $5.47
- 12/28/22
- Cal-Maine Foods reports Q2 EPS $4.07, consensus $4.24
- 02/02/23
- Cardinal Health raises FY23 EPS view to $5.20-$5.50 from $5.05-$5.40
- 02/02/23
- Cardinal Health reports Q2 EPS $1.32, consensus $1.14
- 02/01/23
- Notable companies reporting before tomorrow's open
- 03/02/23
- Burlington Stores sees Q1 adjusted EPS 85c-95c, consensus 82c
- 03/02/23
- Burlington Stores sees FY23 adjusted EPS $5.50-$6.00, consensus $6.65
- 03/02/23
- Burlington Stores reports Q4 adjusted EPS $2.96, consensus $2.73
- 03/29/23
- Bluebird Bio reports Q4 EPS (38c), consensus (44c)
- 11/07/22
- Bluebird Bio reports Q4 EPS (94c) vs, ($3.16)
- 11/07/22
- Bluebird Bio reports Q4 EPS (94c) vs, ($3.16)
ARCT Arcturus Therapeutics - 03/28/23
- Arcturus Therapeutics reports Q4 EPS $4.33, consensus 98c
- 11/09/22
- Arcturus Therapeutics reports Q3 EPS ($1.33), consensus ($1.81)
|